Insider · CIK 0001851664

Ellis Christopher

Reports to the SEC for 1 company · OXFORD, X0

sec.gov

Transactions

Companies

Filings

CIK

0001851664

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-03	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Chief Operating Officer	AAward	+105K sh	—	—	105,000
2022-08-25	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−39.2K sh	—	—	980
2022-08-25	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+39.2K sh	$0.00	+$15.67	39,251
2022-08-25	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Operating Officer	SSale	−14.2K sh	$5.69	−$80.7K	25,075
2022-08-25	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Operating Officer	SSale	−25K sh	$7.07	−$177K	75
2022-08-24	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+450 sh	$0.00	+$0.18	525
2022-08-24	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Operating Officer	SSale	−450 sh	$4.78	−$2,152.215	75
2022-08-24	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−450 sh	—	—	40,156
2022-08-18	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Operating Officer	SSale	−2,175 sh	$4.84	−$10.5K	75
2022-08-18	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,175 sh	—	—	40,606
2022-08-18	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,175 sh	$0.00	+$0.87	2,250
2022-08-17	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+649 sh	$0.00	+$0.26	724
2022-08-17	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−649 sh	—	—	42,781
2022-08-17	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Operating Officer	SSale	−649 sh	$4.77	−$3,092.745	75
2022-08-16	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,200 sh	$0.00	+$0.88	2,275
2022-08-16	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Operating Officer	SSale	−2,200 sh	$4.78	−$10.5K	75
2022-08-16	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,200 sh	—	—	43,430
2022-08-15	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,350 sh	—	—	45,630
2022-08-15	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,350 sh	$0.00	+$2.14	5,425
2022-08-15	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Operating Officer	SSale	−5,350 sh	$4.76	−$25.5K	75
2022-06-28	BRNSBarinthus Biotherapeutics plc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5 sh	$0.00	+$0.002	80
2022-06-28	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5 sh	—	—	50,980
2022-06-28	BRNSBarinthus Biotherapeutics plc.S Sale	Chief Operating Officer	SSale	−5 sh	$6.00	−$30	75
2022-01-03	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Chief Operating Officer	AAward	+80K sh	—	—	80,000
2021-05-04	BRNSBarinthus Biotherapeutics plc.P Purchase	Chief Operating Officer	PPurchase	+75 sh	$17.00	+$1,275	75
2021-04-29	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Chief Operating Officer	AAward	+5,708 sh	—	—	5,708
2021-04-29	BRNSBarinthus Biotherapeutics plc. · Share Option (Right to Buy)A Award	Chief Operating Officer	AAward	+97.3K sh	—	—	97,335

Recent filings

Accepted (ET)
Feb 234
Ellis Christopher0001104659-23-024801
SEC(opens sec.gov)
Aug 264
Ellis Christopher0001104659-22-095142
SEC(opens sec.gov)
Aug 194
Ellis Christopher0001104659-22-092960
SEC(opens sec.gov)
Aug 174
Ellis Christopher0001104659-22-092177
SEC(opens sec.gov)

Companies

Barinthus Biotherapeutics plc.Chief Operating OfficerBRNS

Address

C/O VACCITECH PLC, THE SCHRODINGER BLDG HEATLEY ROAD, THE OXFORD SCIENCE PARK

OXFORD, X0, 0X4 4GE